Boling Clinical Trials Medical Corporation - CA San Bernardino, Upland 91786

Boling Clinical Trials Medical Corporation entered the industry of Medical Research in 1994 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 541720, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.

To acquire more information, please contact Eugene Boling by calling (909) 982-4252 during business hours. You can also write to the business’ Single Location at 510 North 13th Avenue # 302, Upland, California CA 91786. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Boling Clinical Trials Medical Corporation
Representative: Eugene Boling
Place of Business: 510 North 13th Avenue # 302, Upland, CA 91786
Contact Number: (909) 982-4252
Type of Service: Medical Research
SIC Number: 8733
NAICS Number: 541720
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 1994
Income/Year: $1.000.000 to $2.499.999
Laborers: 1 to 4
Share This Company:

Boling Clinical Trials Medical Corporation is a company operating from San Bernardino, California providing professional Medical Research and relevant B2B variables. It was founded in 1994 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 541720 as Medical Research.

With a current employee count of 1 to 4, Boling Clinical Trials Medical Corporation has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Eugene Boling at (909) 982-4252 for related queries, or to locate its Single Location using the coordinates .

The Single Location can also be found at the street address 510 North 13th Avenue # 302 in Upland, California 91786 and can be engaged online through the company website at , the company Twitter , and Facebook page .